A Phase 1 Study of Mosliciguat in Healthy, Adult Males
NCT: NCT07185321 · COMPLETED
NCT IDNCT07185321
StatusCOMPLETED
Start Date2025-06-10
Completion2025-07-13
SponsorPulmovant, Inc. (INDUSTRY)
First posted
Last updated
Brief Summary
This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.
Frequently Asked Questions
What is A Phase 1 Study of Mosliciguat in Healthy, Adult Males?
A Phase 1 Study of Mosliciguat in Healthy, Adult Males is a clinical trial registered under NCT07185321. Current status: COMPLETED.
What is the status of NCT07185321?
The current status of NCT07185321 (A Phase 1 Study of Mosliciguat in Healthy, Adult Males) is: COMPLETED.
When did A Phase 1 Study of Mosliciguat in Healthy, Adult Males start?
A Phase 1 Study of Mosliciguat in Healthy, Adult Males started on 2025-06-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.